This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.
Study Type
OBSERVATIONAL
Enrollment
1,000
NYU Langone Health
New York, New York, United States
RECRUITINGTreatment Complications
Time frame: Up to Year 15
PSA-Progression Free Survival
Length of time following cryotherapy for ablation treatment of prostate cancer that a patient lives without their prostate-specific antigen (PSA) levels rising significantly enough to indicate disease recurrence, or without dying from any cause.
Time frame: Up to Year 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.